{"id":"W2885983462","doi":"10.1158/1535-7163.targ-17-a152","title":"Abstract A152: Emerging indications for kinase-targeted therapies: screening for new targets","year":2018,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"SignalChem (Canada)","funders":"","keywords":"Kinome; Kinase; Vandetanib; Tyrosine kinase; Receptor tyrosine kinase; Medicine; Pharmacology; Cabozantinib; Cancer research; Sorafenib; Biology; Cancer; Biochemistry; Signal transduction; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005669049,0.000679851,0.0008030437,0.0007652733,0.0001574834,0.0008973744,0.0004769419,0.0006884263,0.004171658],"category_scores_gemma":[0.0002652617,0.0002015957,0.0005676094,0.0005157062,0.0002161997,0.0004658621,0.0002914176,0.001263541,0.001474102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005389068,"about_ca_system_score_gemma":0.0004610408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006001524,"about_ca_topic_score_gemma":0.001855091,"domain_scores_codex":[0.9998172,0.00004510011,0.00001379288,0.00002970444,0.00006017819,0.00003396422],"domain_scores_gemma":[0.9998423,0.00002612182,0.00003109466,0.00001019245,0.00004530329,0.00004497826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002708059,0.001435174,0.002365742,0.001874897,0.0001789753,0.0008977322,0.0000906157,0.003019995,0.7914581,0.002183993,0.007008072,0.1867786],"study_design_scores_gemma":[0.003414023,0.05116393,0.02169192,0.00108862,0.0008056808,0.005976566,0.0003061451,0.01315689,0.6675162,0.003049314,0.2316613,0.0001693879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6643637,0.2807292,0.01431395,0.004545783,0.0007297745,0.001052507,0.004377651,0.0005502749,0.02933707],"genre_scores_gemma":[0.8341279,0.1307611,0.0116268,0.002364445,0.0003479386,0.0003936218,0.005254653,0.00008819602,0.01503541],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004171658,"threshold_uncertainty_score":0.01395565,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0617206210391006,"score_gpt":0.3774012130918977,"score_spread":0.3156805920527971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}